Do these 3 things before closing this tab:
1Scan for outdated or missing drivers - takes under a minute2Repair Windows errors before they cause bigger problems3Fix the driver behind crashes, sound loss and screen glitchesNeither Cameco nor a uranium ETF is a direct, guaranteed proxy for the spot uranium price. Cameco shares concentrate exposure in one company with several nuclear-fuel businesses; an ETF spreads exposure across a basket, which can still hold a large position in Cameco. The better fit depends on whether you want company-specific exposure, a broader sector basket, or a fund that also holds physical uranium.
What is the difference between Cameco stock and uranium ETFs?
Buying Cameco stock means owning equity in Cameco Corporation. Buying URA or URNM means owning shares in a fund whose value reflects a portfolio of securities—and, for URNM, exposure that includes physical uranium. These are different routes into the uranium and nuclear industries, not interchangeable ways to buy uranium itself.
| Comparison | Cameco shares | URA | URNM |
|---|---|---|---|
| What you own | Equity in one operating company with activities across the nuclear fuel cycle. | Fund shares tracking an index of uranium and nuclear-component businesses before fees and expenses. | Fund shares focused on uranium miners and physical uranium; Sprott says the fund invests at least 80% of assets in securities of its benchmark index. |
| Exposure emphasis | Cameco’s operations, contracts, costs and execution across its businesses. | A broader basket that includes uranium-related companies and nuclear-component businesses. | A more focused miner and physical-uranium approach, as described by Sprott. |
| Issuer-reported Cameco weight | 100% of the company exposure is Cameco. | 21.80% on October 2, 2026; Global X reported 58 holdings. | 19.23% on September 9, 2026. |
| Reported fund expense | No ETF operating expense; trading and ownership costs depend on the venue and investor. | 0.69% total expense ratio, per Global X issuer data reported in October 2026. | 0.75% net total expense ratio, per Sprott issuer data dated September 9, 2026. |
The fund weights are separate issuer snapshots from different dates, not a same-day comparison. Holdings and expenses can change; consult each issuer’s latest disclosures before making a decision.
What owning Cameco shares means
Cameco is an operating company, not a uranium-price fund. Its 2025 annual information form describes exploration and uranium production, refining, UO2 and UF6 conversion, CANDU fuel manufacturing, an investment in Westinghouse, and an investment in GLE enrichment technology. Company results therefore depend on more than the uranium price: operating performance, production, contracts, costs, regulation and its other businesses also matter. See Cameco’s 2025 annual information form.
Cameco stated that its tier-one production represented 15% of world production in 2025 and listed approximately 433 million pounds of proven and probable uranium reserves in its 2025 AIF. Those are company-reported figures for the stated reporting period, not measures of future investment performance.
In its 2025 annual report, Cameco reported 21.0 million pounds of uranium production attributable to its share for 2025 and planned 19.5–21.5 million pounds attributable to its share for 2026. The latter is a company plan, not a guaranteed result; the company’s 2025 annual report and outlook also discuss delivery volumes, realized prices and costs.
Do Cameco shares track the uranium price?
Not mechanically. Cameco sells uranium through contracts, including base-escalated and market-related contracts. The company disclosed that its average realized uranium price improved in 2025 as prices under those contracts increased. Contract terms and timing mean realized prices need not move in step with the spot market, and Cameco’s broader operations add company-specific influences. Its annual disclosures discuss these commercial and operating factors.
What URA offers
Global X says URA seeks to provide investment results that correspond generally, before fees and expenses, to the price and yield performance of the Solactive Global Uranium & Nuclear Components Total Return Index. The issuer describes the index universe as including firms involved in uranium extraction, refining and exploration as well as nuclear-industry equipment manufacturing. That wider scope is a key distinction from buying Cameco alone. See Global X’s URA fund page.
PC Slower Than It Used to Be?
A free scan shows the junk files, broken settings and background clutter dragging Windows down - then fixes them in one click.Free scan · Windows 10 & 11Outdated Drivers Are Slowing You Down
One free scan finds every outdated or missing driver and matches the right update for your exact hardware.Free scan · exact hardware matchGlobal X reported 58 holdings and a 0.69% total expense ratio in October 2026; its Cameco weight was 21.80% on October 2, 2026. These issuer figures are dated snapshots, not permanent fund characteristics. A basket diversifies company-specific exposure, but it does not remove sector risk: holdings can respond to similar uranium or nuclear-industry factors, and Cameco remained a substantial position in that snapshot.
What URNM offers—and whether it owns physical uranium
Yes. Sprott describes URNM as focused on uranium miners and physical uranium, and says the fund’s policy is to invest at least 80% of its total assets in securities of the VettaFi Global Uranium Mining Index (URNMX). The index, as described in Sprott’s Q1 2026 factsheet, is designed to track companies devoting at least 50% of assets to uranium mining—including mining, exploration, development and production—or holding physical uranium, owning royalties, or supporting the industry through other activities. See Sprott’s URNM page.
Sprott’s Q1 2026 factsheet reported a 17.63% physical uranium industry weighting as of March 31, 2026. This is a dated portfolio figure, not a guarantee of the fund’s future allocation. Sprott listed a 0.75% total annual operating expense ratio in its fund materials and reported a 0.75% net total expense ratio on September 9, 2026. Its issuer page listed Cameco at 19.23% on that same September 9 snapshot.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Which is a better fit for your uranium exposure?
Consider Cameco if you want one-company exposure
- You want your investment thesis to focus on Cameco’s operations and business execution rather than a basket of industry companies.
- You are comfortable with company-specific production, contract, cost, regulatory and wider business risks.
- You understand that contracts and multiple business lines can make the relationship between Cameco’s share price and spot uranium prices indirect.
Consider URA if you want a broader uranium-and-nuclear basket
- You want exposure to multiple companies, including nuclear-component businesses as well as uranium-related firms.
- You accept that a diversified basket may still have a substantial Cameco position and can remain exposed to shared sector trends.
- You are comfortable paying the fund’s reported expense ratio and reviewing changing holdings.
Consider URNM if you want a miner-focused fund with physical uranium exposure
- You want a fund Sprott describes as focused on uranium miners and physical uranium.
- You value the possibility of physical-uranium exposure within a fund, while recognizing that its reported weighting is dated and may change.
- You accept the fund’s reported expenses and the risks of a focused industry portfolio.
What this comparison cannot establish
The reviewed issuer disclosures do not establish that Cameco, URA or URNM will outperform the others. Their exposures are not identical, and dated holdings or past operating figures cannot determine future returns. Compare each investment’s current documents, holdings and expenses against your intended exposure and risk tolerance. This is general educational information, not individualized financial or tax advice.
Recommended Free Tools
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
